Osaic Holdings
SGMT icon

Osaic Holdings’s Sagimet Biosciences SGMT Stock Holding History

Osaic Holdings’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Buy
+1
New +$7 ﹤0.01% 7949
2025
Q2 		– Sell
-10
Closed -$32 – 7870
2025
Q1 		$32 Buy
+10
New +$42 ﹤0.01% 7320

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Osaic Holdings's SGMT Position: Q2 2026 in Review

Osaic Holdings opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 1 share worth $8. The stake represents ﹤0.01% of the portfolio and ranks #7949 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in SGMT as recently as Q1 2025.

Osaic Holdings first reported a position in SGMT in Q1 2025 and has held it in 2 quarters since. The position peaked at $32 in Q1 2025. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Osaic Holdings held 1 share of Sagimet Biosciences worth $8 as of Q2 2026.
  • Sagimet Biosciences was a new Osaic Holdings position in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7949 holding.
  • Osaic Holdings first reported a position in Sagimet Biosciences in Q1 2025 and has held it in 2 quarters since.
  • Osaic Holdings's Sagimet Biosciences position peaked at $32 in Q1 2025.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.